investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Informatic Methods for Differential Signaling and Immune Co-Regulatory Expression
Kevin Hasegawa Eng
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Kevin Hasegawa Eng
Roswell Park Cancer Institute
Buffalo, United States
Related projects
Shyam Sharan
Identification of Genetic Interactors of Brca2
Ovary
Xiaolu Yang
Role of p53 Family Proteins in Glucose Metabolism
Ovary
Pathology
Parijat Bhatnagar
Cellular biofactories for therapeutic protein synthesis in tumor microenvironment
Ovary
Neil Johnson
Identifying BRCA1 protein variants that provide resistance to therapy
Ovary
The Role of microRNA, mir-30d, in the Initiation and Progression of Cancer
Ovary
Selvendiran Karuppaiyah
Dissecting the Role of STAT3 and Targeting Ovarian Cancer
Ovary
Hematology and hematologic malignancies
Pathology
Martin Brechbiel
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
Ovary
Shelley S Tworoger
Psychological stress, associate biologic mediators, and ovarian cancer risk
Ovary
Martin Mcintosh
Profiling cancer neoantigen repertoires and validating immunotherapy targets
Ovary